Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SARS Diagnostics Workshop July 14 Would Facilitate Lab Resource Exchange

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center sees the severe acute respiratory syndrome outbreak as an opportunity to address the scientific challenges of developing new diagnostics when a disease remains ill-defined
Advertisement

Related Content

IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
IVD Reps Propose Alternative 510(k) Route For In Vitro Analytical Tests
FDA, CDC Address Disease Outbreak Test Development In Wake Of SARS
FDA, CDC Address Disease Outbreak Test Development In Wake Of SARS
Advertisement
UsernamePublicRestriction

Register

MT018641

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel